Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Non-Current Deferred Tax Liability (2016 - 2018)

Medifast (MED) has disclosed Non-Current Deferred Tax Liability for 9 consecutive years, with $16000.0 as the latest value for Q1 2018.

  • For the quarter ending Q1 2018, Non-Current Deferred Tax Liability fell 97.46% year-over-year to $16000.0, compared with a TTM value of $16000.0 through Mar 2018, down 97.46%, and an annual FY2017 reading of $208000.0, down 73.3% over the prior year.
  • Non-Current Deferred Tax Liability was $16000.0 for Q1 2018 at Medifast, down from $208000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $6.6 million in Q1 2014 and bottomed at $16000.0 in Q1 2018.
  • Average Non-Current Deferred Tax Liability over 5 years is $3.5 million, with a median of $4.8 million recorded in 2015.
  • The sharpest move saw Non-Current Deferred Tax Liability grew 7.61% in 2015, then tumbled 97.46% in 2018.
  • Year by year, Non-Current Deferred Tax Liability stood at $5.5 million in 2014, then dropped by 10.96% to $4.9 million in 2015, then plummeted by 84.07% to $779000.0 in 2016, then plummeted by 73.3% to $208000.0 in 2017, then crashed by 92.31% to $16000.0 in 2018.
  • Business Quant data shows Non-Current Deferred Tax Liability for MED at $16000.0 in Q1 2018, $208000.0 in Q4 2017, and $196000.0 in Q2 2017.